2024 annual financial data
Cellyan Biotechnology 2024 Net margin
Direct answer
Net margin was 7.97%.
Operating income was 1,608,261 USD and net income was 1,329,717 USD.
Operating cash flow was -394,330 USD.
Get free Cellyan Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 16,688,364 USD
- Operating income
- 1,608,261 USD
- Net income
- 1,329,717 USD
- Operating cash flow
- -394,330 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Cellyan Biotechnology financial years